Zimmer Biomet Holdings Inc
NYSE:ZBH
Relative Value
The Relative Value of one ZBH stock under the Base Case scenario is 184.72 USD. Compared to the current market price of 119.75 USD, Zimmer Biomet Holdings Inc is Undervalued by 35%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ZBH Competitors Multiples
Zimmer Biomet Holdings Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
24.6B USD | 3.3 | 24 | 12 | 19.7 | ||
US |
Abbott Laboratories
NYSE:ABT
|
185.3B USD | 4.6 | 32.9 | 19.4 | 28.9 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.3B USD | 18.1 | 66.6 | 54.6 | 68.4 | ||
US |
Stryker Corp
NYSE:SYK
|
128.2B USD | 6.3 | 40.5 | 25.2 | 31.2 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.4B USD | 7.5 | 68.4 | 31.8 | 47.4 | ||
IE |
Medtronic PLC
NYSE:MDT
|
105.4B USD | 3.3 | 25.1 | 13.4 | 19 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
66.6B USD | 3.4 | 54.6 | 18.3 | 38.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.3B EUR | 2.7 | 38.4 | 18.4 | 31.1 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
53.2B USD | 14.7 | 98.2 | 66.2 | 86.2 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.9B USD | 8.8 | 37.7 | 27.3 | 29.6 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |